NeoGenomics Reports First Quarter 2024 Results
First Quarter Revenue Increased 14% to $156 Million FORT MYERS, Fla.–(BUSINESS WIRE)–NeoGenomics, Inc. (NASDAQ: NEO) (the “Company”), a leading provider... Read more.
Silvaco Announces Launch of Initial Public Offering
SANTA CLARA, Calif.–(BUSINESS WIRE)–Silvaco Group, Inc. (“Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable semiconductor... Read more.
FINOS launches AI Readiness as the cornerstone effort of an industry-wide open-source AI initiative for Financial Services.
FINOS Members including Citi, Scott Logic, Morgan Stanley, ControlPlane, Microsoft, London Stock Exchange Group, Publicis Sapient, Databricks, EPAM and Provectus... Read more.
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule... Read more.
Envoy Research Reveals One-Third of Organizations Struggle with Workplace Management; 53% Lack Necessary Decision-Making Data
SAN FRANCISCO–(BUSINESS WIRE)–Envoy, the only integrated workplace platform that connects people, spaces, and data, today published the eBook, “Tomorrow’s... Read more.
Corning Reports First-Quarter 2024 Financial Results
Management reaffirms expectation that first-quarter sales will mark the low point of the year, as improving market conditions support higher sales throughout 2024... Read more.
Facteus Launches Data Sets Highlighting Consumer Cross Shopping Behavior
First-of-its-kind insights to uncover consumer shopping habits available publicly PORTLAND, Ore.–(BUSINESS WIRE)–#altdata—Facteus, the largest... Read more.
Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition
MONTREAL & LAUSANNE, Switzerland–(BUSINESS WIRE)–Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage... Read more.
Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition
LAUSANNE, Switzerland & MONTREAL–(BUSINESS WIRE)–Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming... Read more.
Strayer University Names Dr. Antoinette ‘Toni’ Farmer-Thompson President
WASHINGTON–(BUSINESS WIRE)–Strayer University, a higher learning institution for working adults, has announced Dr. Antoinette ‘Toni’ Farmer-Thompson... Read more.